Here we have paired data. Let d = Deanol - Placebo
Following table shows the calculations:
Deanol | Placebo | d=test1-test2 | (d-mean)^2 |
12.4 | 9.2 | 3.2 | 5.6644 |
6.8 | 10.2 | -3.4 | 17.8084 |
12.6 | 12.2 | 0.4 | 0.1764 |
13.2 | 12.7 | 0.5 | 0.1024 |
12.4 | 12.1 | 0.3 | 0.2704 |
7.6 | 9 | -1.4 | 4.9284 |
12.1 | 12.4 | -0.3 | 1.2544 |
5.9 | 5.9 | 0 | 0.6724 |
12 | 8.5 | 3.5 | 7.1824 |
1.1 | 4.8 | -3.7 | 20.4304 |
11.5 | 7.8 | 3.7 | 8.2944 |
13 | 9.1 | 3.9 | 9.4864 |
5.1 | 3.5 | 1.6 | 0.6084 |
9.6 | 6.4 | 3.2 | 5.6644 |
Total | 11.5 | 82.5436 |
---------------------------------------------------------------
PROBLEM #3: Tardive dyskinesia denotes a syndrome comprising a variety of abnormal involuntary movements assumed to...
PROBLEM #3: dyskinesia denotes a syndrome comprising a variety of abnormal involuntary 15 assumed to follow long-term use of antipsychotic drugs. In an experiment to sce whether the drug deanol produced a greater improvement from base-line scores than a placebo treatment (“Double Blien Evaluation of Deanol in Tardive Dyskinesia," J. Amer. Med. Assn., 1978, pp. 1997-1998), the two treatments were administered for four- weeks each in random order to 14 patients, resulting in the following total severity index (TSI) scores:...